We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed

Medical Marijuana, Inc. (MJNA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0137+0.0001 (+1.11%)
At close: 3:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0135
Open0.0140
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0132 - 0.0141
52 Week Range0.0100 - 0.0400
Volume4,647,987
Avg. Volume9,356,062
Market Cap57.115M
Beta (5Y Monthly)-0.19
PE Ratio (TTM)6.82
EPS (TTM)0.0020
Earnings DateApr 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie Award Winners in 2020 International Business Awards
    GlobeNewswire

    Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie Award Winners in 2020 International Business Awards

    MJNA Medical Marijuana, Inc. and Subsidiaries Honored as Stevie Award Winners in 2020 International Business AwardsSAN DIEGO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company and its subsidiaries received four prestigious Stevie® Awards in The 17th Annual International Business Awards®, the world's only international, all-encompassing business awards program.  Notably, Medical Marijuana, Inc. CEO Dr. Stuart Titus was honored with a Gold Stevie® Award for Executive of the Year - Food & Beverage.The Company and its subsidiaries were also recognized for the following: * HempMeds®: Gold Stevie® Award for Consumer Products - Food & Beverage * Kannaway® CEO Blake Schroeder: Silver Stevie® Award for Maverick of the Year * Kannaway®: Bronze Stevie® Award for Achievement in International Expansion“Having the opportunity to lead Medical Marijuana, Inc.’s talented team for over a decade has been an honor in itself and I am humbled to be chosen as a Gold Winner for Executive of the Year,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “I look forward to continuing to lead this Company of Firsts as we trailblaze even more innovation for the hemp-based CBD industry.”Winners of The 17th Annual International Business Awards® were selected from more than 3,800 nominations submitted by organizations in more than 60 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide.“Expanding access to CBD across the globe has taken great determination and extensive education efforts,” said Kannaway® CEO Blake Schroeder. “I am honored and humbled to be recognized as a Maverick of the Year for pushing forward Kannaway’s international expansion.”Details about The 17th Annual International Business Awards® and the list of 2020 Stevie® winners are available at https://stevieawards.com/iba. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.About the Stevie® AwardsStevie Awards are conferred in eight programs: the Asia-Pacific Stevie Awards, the German Stevie Awards, the Middle East & North Africa Stevie Awards, The American Business Awards®, The International Business Awards®, the Stevie Awards for Great Employers, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Stevie Awards competitions receive more than 12,000 entries each year from organizations in more than 70 nations. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at http://www.StevieAwards.com.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT: Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.comAttachment * MJNA

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces August 2020 as the Best Revenue Month in Company History

    SAN DIEGO, CA, Sept. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in August 2020. “Since 2015, HempMeds® Brasil has sold more than 80,000 units of cannabidiol (CBD) to Brazilian citizens,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are proud to be the recipients of the first permits to import CBD into Brazil and we have been able to become industry leaders there.”“Our Company was formed and is led by Brazilians – we care immensely about providing people here with affordable, high-quality CBD products that are legal and scientifically-proven,” said HempMeds® Co-CEO Caroline Heinz. “We have showcased to citizens even despite a global pandemic and a very poor currency exchange rate, we have been able to increase our sales and make our products affordable for the struggling economy through adjusting our prices and offering payment plans.”Before becoming Co-CEO of HempMeds®’ operations, Heinz served as Vice President of HempMeds® Brasil. She joined the Company in 2014 and helped pass legislation to get the Brazilian government to subsidize CBD for several indications. She was also able to establish two HempMeds® Brasil offices and create a network of Brazilian doctors and medical professionals.To learn more about HempMeds® Brasil, please visit them online at https://hempmedsbr.com/ or on Instagram at https://www.instagram.com/hempmedsbrasil/.About HempMeds® Brasil HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (Anvisa) to import a product based on cannabidiol, a substance derived from hemp, a plant of the genus Cannabis. Currently, it is authorized to supply its products, which help in the control of diseases such as epilepsy, Parkinson's, chronic pain and multiple sclerosis, under medical prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil is working on additional approvals for other indications. www.hempmeds.com.br. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.com Investor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com

  • Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as 2020 CEO World Award Winners
    GlobeNewswire

    Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as 2020 CEO World Award Winners

    MJNA Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as 2020 CEO World Award WinnersSAN DIEGO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company and its subsidiary Kannaway® have received two prestigious CEO World Awards in the 8th Annual 2020 CEO World Awards. Kannaway® CEO Blake Schroeder was honored with a Silver Award for Top CEO of the Year - The Maverick for his efforts in leading the company’s impressive international expansion throughout recent years.Medical Marijuana, Inc. CEO Dr. Stuart Titus was named a Bronze Award winner for Top CEO of the Year - The Visionary for guiding the Company through over a decade of “firsts” in the hemp-derived cannabidiol (CBD) industry.“We are passionate about spreading access to high-quality CBD across the globe and doing so has meant trailblazing new paths for the industry over the last decade,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is an honor to be recognized but we still have much work to do as an industry.”The CEO World Awards are an annual industry and peers recognition program honoring CEOs, executives, entrepreneurs, innovators, and their management teams from organizations in every industry and of every size in Asia, Australia and New Zealand, Canada and the USA, Europe, Mexico, the Caribbean and Central and South America, the Middle East and Africa. The Annual CEO World Awards is part of the SVUS Awards® recognition program from Silicon Valley. The coveted annual CEO World Awards program encompasses the world’s best in leadership, innovation, organizational performance, new products and services, excellence studies, corporate social responsibility, and milestones from every major industry in the world.“International expansion has been a key focus for Kannaway in recent years and we expect that to continue as we look into our future,” said Kannaway® CEO Blake Schroeder. “Our accomplishments in 2019 propelled our expansion in Europe and Asia and we intend to continue pushing forward with that momentum.”About Kannaway®Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT: Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.comAttachment * MJNA

  • Medical Marijuana, Inc. Subsidiary Kannaway® Signs Trademark License and Royalty Agreement with Direct Selling Pet Food Company, Onboards Company's Brand Ambassadors
    GlobeNewswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Signs Trademark License and Royalty Agreement with Direct Selling Pet Food Company, Onboards Company's Brand Ambassadors

    MJNA Kannaway® Signs Trademark License and Royalty Agreement with Direct Selling Pet Food Company The Best FriendSAN DIEGO, CA, Sept. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has signed a Trademark License and Royalty Agreement with direct selling company The Best Friend (“TBF”). As a part of the agreement, the new venture, TBF by Kannaway®, will sell a super-premium line of veterinarian-developed pet food products, as well as a line of cannabidiol (CBD) tinctures designed for pets, throughout Europe.These pet food products are created by a research and development team composed of world-renowned premium dog breeders, scientists and veterinarians. They have been designed to meet the strictest requirements for quality, nutritional value, consistency, digestibility, and have a low risk of allergy reactions. The new line of TBF best-selling super-premium feeds includes:• Beef & Rice 3kg• Lamb & Rice 3kg• Junior Complex 3kg“CBD hemp oil has been researched by top veterinarians to improve cardiovascular, orthopedic and mental animal health,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re excited to be able to offer some of the highest-quality pet food products in Europe and soon launch a new line of CBD products that can nicely supplement them.” Brand ambassadors who were previously selling TBF products exclusively will now market and sell The Best Friend by Kannaway® as well as other CBD products through Kannaway®’s expansive direct selling network. “According to Grandview Research, Europe’s market for pet food in 2018 was the largest pet food market in the world and that growth only continues with a global pet food market that is expected to reach $113.08 billion by 2025,” said Kannaway® CEO Blake Schroeder. “Joining forces with TBF will not only allow us to expand our product offering and gain an entirely new subset of customers, but it will also allow TBF distributors to earn another source of revenue.”TBF was founded just 13 months ago by Tobias Sukenik, Michal Kyselica and Michal Prazenica, and has already achieved tremendous growth. Currently, TBF has over 10,000 registered partners in 6 countries, making it one of the fastest-growing pet direct selling companies in Europe. To learn more about The Best Friend by Kannaway®, please visit http://www.kannaway.com and attend the upcoming Kannaway® Europe webinar on September 10. About Kannaway®Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.com Investor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.comAttachment * MJNA

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary Kannaway®’s Japanese Division Announces August 2020 as Best Revenue Month in Company History

    SAN DIEGO, CA, Sept. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best revenue month ever in Company history in July 2020. “The hemp-derived cannabidiol (CBD) market in Asia has exploded over the past year and, despite a global pandemic, this market continues to gain new consumers who are eager to take part,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are proud to be one of the pioneers in bringing CBD to Japan and look forward to accomplishing many more financial and operational milestones in this country and other Asian countries in the near future.”China and Japan present a large opportunity for Kannaway® as, according to Prohibition Partners, they collectively account for about 90 percent of Asia’s CBD market. The CBD market in Asia is projected to be worth $5.8 billion by 2024.“We are excited about our growth in Japan and look forward to continuing to develop the marketplace,” said Kannaway® CEO Blake Schroeder.About Kannaway®Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.com Investor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com

  • Medical Marijuana, Inc. Announces Production and Warehouse Facility Expansion; Adds State-of-the-Art Manufacturing Capability and Hemp License
    GlobeNewswire

    Medical Marijuana, Inc. Announces Production and Warehouse Facility Expansion; Adds State-of-the-Art Manufacturing Capability and Hemp License

    MJNA Medical Marijuana, Inc. Announces Production and Warehouse Facility ExpansionSAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first cannabis-derived nutraceutical products, brands and supply chain, announced today the expansion of its production and warehouse facility, further vertically integrating the Company’s supply chain, enabling broader product R&D and internal manufacturing. The Company has added 1,100 square feet of production area to its 16,000-square-foot facility. The facility continues to meet cGMP requirements and is registered with the FDA as well as the local authorities. Medical Marijuana, Inc. will produce, encapsulate and package 80 percent of all of its products, such as cannabidiol (CBD)-based topicals, liquids, capsules, and powders, in-house. “This was a strategic and important decision for us -- to develop and utilize our resources to their greatest potential and find new ways to create value for our portfolio of companies,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This facility will decrease our dependence on third-party manufacturers and allows for us to oversee our supply chain, from seed-to-sale. We are able to decrease turnaround times on products, allow for management of run rates and timelines that are company controlled, and creates a whole new opportunity to significantly grow and manage our business.” In addition to having the ability to manufacture its own high-quality hemp cannabidiol (CBD) products and other supplements, this facility allows Medical Marijuana, Inc. to create an additional revenue source by working with other companies to create, manufacture, brand and distribute a broad array of cannabis and non-cannabis food and nutritional supplement-based products as well as personal care products. “We created the first hemp-derived CBD product and pipeline in the world and expanding our own internal manufacturing and product development capabilities is a testament to the success we have experienced to date. We continue to be a leader in the CBD industry and providing the infrastructure for its supply was a natural progression. Beyond adding additional quality controls and oversight, this facility helps to improve our operations by reducing our cost of goods expenses and increasing margins. Beyond our own brands and products, we look forward to offering our manufacturing expertise and services to other companies who are looking to add to their portfolio, which is a new revenue stream for us,” said Medical Marijuana, Inc. COO Blake Schroeder.For more information on the Company, please visit www.medicalmarijuanainc.com.About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.comAttachment * MJNA

  • GlobeNewswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Begins Recruiting CBD Users for ValidCare Virtual Study™

    SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has begun recruiting cannabidiol (CBD) users to participate in the ValidCare CBD safety study. The nationwide observational study is using its products to measure the potential effects on the liver of orally consumed, hemp-derived CBD products in healthy adults. Participants will provide real-time feedback via ValidCare’s Virtual Study™ platform and supply blood samples for evaluation as part of the study.  “Since day one, we have been dedicated to providing our consumers with safe, consistent products they can trust,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “This study helps us further that commitment and lets us take part in an industry effort to provide further evidence that CBD holds many wellness benefits without harmful side effects.”The IRB-approved study, which was designed to respond to the FDA’s many requests for science-based data, is being conducted by ValidCare and qualifies as a national clinical trial. Kannaway® is one of 13 industry-leading companies to participate and help the FDA determine the regulatory path for hemp-derived CBD products. Each company is responsible for providing lot-specific product information for the study and recruiting a target of 100 consumers to participate. Upon completion of the study, Kannaway will receive safety data pertaining to those specific participants. Consumers are screened to ensure they meet study criteria before they are approved and enrolled. Participants will use Kannaway hemp-derived CBD or CBD isolate products for 30 consecutive days and provide a blood sample. Over 1,000 consumers have expressed interest in being part of the study.“It’s encouraging to see the CBD industry working together to further CBD research,” said Kannaway® CEO Blake Schroeder. “We invest greatly in scientific research, including internal and external independent studies such as ValidCare’s because it is essential to gaining consumer trust.”Results of the study will be shared with the FDA and are expected to be published in a peer-reviewed journal in early 2021. To learn more about the study please visit https://validcare.com/validcare-national-cbd-liver-function-study/.About ValidCareValidCare, LLC provides contract research outsourcing (CRO) and virtual research solutions for life sciences and consumer packaged goods industries.  ValidCare’s proprietary platform supports decentralized, hybrid and virtual research powered by real world evidence (RWE) to deliver insights that help fuel healthier generations. For more information, visit www.validcare.com or call 844-825-4322. About Kannaway Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products. About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com

  • GlobeNewswire

    Medical Marijuana, Inc. Announces Key Executive Team Hire and Promotions

    SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has made several promotions within the organization.  The Company has promoted Todd Morrow, who will now serve as the Chief Financial and Information Officer (CFIO). Michelle Sides, Esq. has been named as the Company’s Chief Legal Officer. In addition, the Company has hired Robert A. Wells Jr. to serve as its Vice President of Finance.Wells was chosen for this position due to his decades of success serving in key financial roles at consumer-facing companies. Most recently, he served as Chief Financial Officer and Chief Operating Officer of DC Labs & EQyss Grooming Products. While there, he planned, implemented and managed the company’s popular product inventory to ensure product demands were met and scaled appropriately. Previously, he served as CFO of the San Diego Padres for 16 years, Chief Operating Officer (COO) and CFO of Anthony Robbins Companies and COO and CFO of DoorTech Industries.“Our Company is well supported by its employees and thus far we’ve been able to curate some of the most talented professionals in the industry,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “As we look forward to updated management roles and new personnel, we are confident in continuing our Company vision as a pioneer in the US Cannabidiol (CBD) market that is expected to reach $9.69 billion by 2025.”While serving as Chief Information Officer, Morrow successfully lead strategic decision-making, cross-collaboration and driving greater profitability within the organization's family of companies. As CFIO, Morrow will continue to support the Company’s financial success through his keen eye for consumer demand and market strategy. As a CBD industry co-founder, Sides has long shared Medical Marijuana, Inc.’s vision of changing lives by offering high-quality CBD product. She has held several executive positions within the Company, including Chairman and COO, and has been part of the Board of Directors since 2011. In her role as Chief Legal Officer, Sides will guide the Company through her deep knowledge of legal and regulatory requirements. “After being deeply entrenched in Medical Marijuana, Inc.’s affairs over the years, I am excited to transition into this new role for the Company that I put my heart and soul into co-founding many years ago,” said Sides. “I could not be more proud of what our Company has accomplished, the changes we have made in this industry and the difference we have made in millions of lives. I am incredibly excited about what is ahead and have complete confidence in the talented executive team we have assembled to guide the company’s continued success.”About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com

  • GlobeNewswire

    Medical Marijuana, Inc. Announces Sales Operations Milestone; Sells More Than 1.6 Billion Milligrams of CBD

    SAN DIEGO, Aug. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a significant operational milestone of selling and shipping more than 1.6 billion milligrams of hemp-based cannabidiol (CBD) since 2017. The Company’s milestone comes at a time when e-commerce CBD sales have seen a sharp increase as four out of 10 CBD consumers plan to use CBD oil more frequently during the COVID-19 pandemic and 15 percent of those consumers plan on using a higher dose of CBD than usual. “For a decade, our Company has offered the highest potency CBD product in an oral applicator form through our flagship product, Real Scientific Hemp Oil™. We’ve seen international media coverage of our customers having positive experiences with our products for over half of a decade,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Many products on the market today use isolate forms of CBD, or contain no CBD at all, marketing themselves as ‘hemp oil.’ While we are glad to have such high demand for CBD products, we’re also proud to remain one of the highest quality CBD oils on the market.”As one of the pioneers of the American hemp CBD industry, Medical Marijuana, Inc. has advocated for the compound for over a decade and the Company’s products have remained popular among consumers as mass awareness of CBD rapidly increases. Today, over 62 percent of Americans recognize CBD and/or CBD products and about 33 percent of Americans have used CBD at least once.“We continue to believe in a world where CBD and other cannabinoid-based products are a part of the general population’s everyday wellness routine,” said Medical Marijuana, Inc. COO Blake Schroeder. “While many new companies enter the hemp CBD space, our portfolio of companies was the first to legally offer CBD products derived from industrial hemp.”For more information on the Company, please visit www.medicalmarijuanainc.com.About Medical Marijuana, Inc. We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT:Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com

  • GlobeNewswire

    Medical Marijuana, Inc. Reports 2020 Second Quarter Financial and Operational Results; Reports Net Income of $9.7 Million

    SAN DIEGO, CA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today financial results for the quarter ending June 30, 2020, and provided an overview of recent operational highlights.Second Quarter 2020 Financial and Operational Highlights  * Generated $10.9 million in net revenue in second quarter of 2020; * GAAP Net Income was $9.7 million, as compared to a loss of $15 million for the same period in 2019; * Gross profit for the period ending June 30, 2020, was $8.7 million; * Gross Margins improved for the period, from 74.3% in the second quarter of 2019 to 79.7% in the second quarter of 2020; * GAAP Sales and Marketing expense decreased as a percentage of sales from 52.6% in the second quarter of 2019 to 51.9% in the same period in 2020; * Portfolio investment company Kannalife, Inc. was issued a Notice of Allowance from the United States Patent and Trademark Office (USPTO) on its trademark application for its patented monotherapeutic compound, "Atopidine"; * Subsidiary Kannaway® promoted Chief Marketing Officer Stephen Jones to President; * Blake Schroeder, CEO of the Company's subsidiary Kannaway®, was honored as the Top CEO of the Year by the International Association of Top Professionals; * Subsidiary HempMeds® named Caroline Heinz and Raul Elizalde as co-CEOs; * Subsidiary Kannaway® launched the first-ever cannabidiol (CBD) fitness program, Evolve, in partnership with certified nutrition coach and Kannaway® spokesperson Dan Miller; * The Company and its subsidiaries received five prestigious Stevie® Awards in the 18th Annual American Business Awards®, including the Gold Stevie® Award winner for Company of the Year - Food & Beverage - Small for Medical Marijuana, Inc.; * Investment company AXIM® Biotechnologies, Inc. filed a utility patent application relating to a novel biomarker for the detection of cancer in blood serum and urine; * Subsidiary HempMeds® hired Vince DiMella as its U.S. Director of Sales and Marketing “As the world navigates the financial and logistical burden of the COVID-19 pandemic,  our portfolio of companies has continued to not only operate, but innovate, adapt and expand,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our sales organizations have shifted focus to online sales and virtual events that are experiencing tremendous participation. Our international operations continue to experience growth in distribution, while we push for further acceptance of CBD products in Europe and neighboring countries, where we have a significant presence. Our investment companies AXIM Biotechnologies, Inc. and Kannalife, Inc. have made many noteworthy breakthroughs during the second quarter of this year and we are excited to continue to support them in their scientific missions. Our executive leadership team continues to evolve with the additions and promotions of world-class talent at our home office. All in all, I remain extremely optimistic about the future of Medical Marijuana, Inc.’s portfolio of companies and our positioning in the global cannabis industry.”"Like most, we experienced unprecedented challenges in the second quarter of 2020; however, I could not be prouder of how our team continued to execute throughout the pandemic and regulatory hurdles," said Medical Marijuana, Inc. COO Blake Schroeder. "As a Company of firsts, we knew it would never be easy to introduce wellness products on a global scale but we continue to do just that. Our direct selling organization Kannaway continues to be the primary driver of revenue for our portfolio of companies, specifically in its international operations. Additionally, we have introduced first-of-its-kind wellness and sports programs with renowned experts that elevate our company and products over any of our perceived competitors. We will continue to forge ahead in our mission of bringing the highest quality, most innovative cannabinoid-based products to consumers around the world with a standard of trust and transparency.”Financial Data: Second Quarter 2020 as Compared to First Quarter 2020 (in thousands)Gross Revenue: Q2 2020 – $10,986 Q1 2020 – $13,351Cost of Goods Sold: Q2 2020 – $2,234 Q1 2020 – $2,163Gross Margin: Q2 2020 – 79.7% Q1 2020 – 83.8%Net Income/(Loss): Q2 2020 – $9,699 Q1 2020 – ($90,782)About Medical Marijuana, Inc.We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.CONTACT: Public Relations Contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6600 andrew.hard@cmwmedia.com www.cmwmedia.comInvestor Relations Contact: P. (858) 283-4016 Investors@medicalmarijuanainc.com